单层面平均表观扩散系数可预测非小细胞肺癌脑转移患者对全脑放疗的肿瘤反应
该回顾性研究纳入2012至2016年间接受全脑放疗的102例非小细胞肺癌脑转移患者,于放疗前及放疗开始后12周内行扩散加权MRI,评估感兴趣区单层面平均ADC值及ΔADC对治疗反应、颅内无进展生存和总生存的预测价值。结果显示放疗前高平均ADC值与更好的反应率(72.2% vs 37.5%,p=0.001)和颅内无进展生存(7.6 vs 6.4个月,p=0.031)相关,高ΔADC与更好的反应率相关(73.6% vs 36.7%,p<0.001);作者认为放疗前平均单层面ADC值和放疗后ΔADC可能是颅内肿瘤反应的潜在预测因子。
要点
- 放疗前脑转移灶平均单层面ADC值高者全脑放疗反应率更高(72.2% vs 37.5%,p=0.001)。
- 放疗后ΔADC高者全脑放疗反应率更高(73.6% vs 36.7%,p<0.001)。
- 两位放射科医师测量放疗前、放疗后平均ADC值及ΔADC的观察者间一致性良好(Pearson相关系数分别为0.915、0.950、0.937,p<0.001)。
诊断标准与关键数值
- 高平均ADC值组与低平均ADC值组的治疗反应率分别为72.2%和37.5%(p=0.001)。
- 高平均ADC值组与低平均ADC值组的颅内无进展生存分别为7.6个月和6.4个月(p=0.031)。
- 高ΔADC组与低ΔADC组的治疗反应率分别为73.6%和36.7%(p<0.001)。
- 放疗前、放疗后平均ADC值及ΔADC的观察者间Pearson相关系数分别为0.915、0.950、0.937(p<0.001)。
临床应用与阅片要点
- 作者认为放疗前使用ADC值预测反应可帮助肿瘤科医师制定更好的治疗方案并避免错过挽救治疗的机会。
- 多因素分析显示组织病理学、脑转移灶数目、放疗前高ADC值和放疗后高ΔADC与更好的全脑放疗治疗反应相关。
- 多因素分析显示KPS、脑转移灶数目和放疗前低ADC值增加颅内复发的风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: This study aimed to access the performance of apparent diffusion coefficient (ADC) as a predictor for treatment response to whole-brain radiotherapy (WBRT) in patients with brain metastases (BMs) from non-small-cell lung cancer (NSCLC).
METHODS: A retrospective analysis was conducted of 102 NSCLC patients with BMs who underwent WBRT between 2012 and 2016. Diffusion-weighted MRI were performed pre-WBRT and within 12 weeks after WBRT started. Mean single-plane ADC value of ROIs was evaluated by two radiologists blinded to results of each other. The treatment response rate, intracranial progression-free survival (PFS), and overall survival (OS) were analyzed based on the ADC value and ΔADC respectively. At last, we used COX and logistic regression to do the multivariate analysis.
RESULTS: There was good inter-observer agreement of mean ADC value pre-WBRT, post-WBRT, and ΔADC between the 2 radiologists (Pearson correlation 0.915 [pre-WBRT], 0.950 [post-WBRT], 0.937 [ΔADC], p < 0.001, for each one). High mean ADC value were related with better response rate (72.2% vs 37.5%, p = 0.001) and iPFS (7.6 vs 6.4 months, p = 0.031). High ΔADC were related with better response rate (73.6% vs 36.7%, p < 0.001). Multivariate analysis shows that histopathology, BMs number, high ADC value pre-WBRT, and high ΔADC post-WBRT were related to better treatment response of WBRT, and KPS, BMs number, and low ADC value pre-WBRT increased the risk of developing intracranial relapse.
CONCLUSIONS: The mean single-plane ADC value pre-WBRT and ΔADC post-WBRT were potential predictor for intracranial tumor response to WBRT in NSCLC patients with brain metastases.
KEY POINTS: • ADC value is a potential predictor of intracranial treatment response to WBRT in NSCLC patients with brain metastases. • Higher mean ADC value pre-WBRT and ΔADC post-WBRT of brain metastases were related to better intracranial tumor response. • Prediction of response before WBRT using ADC value can help oncologists to make better therapy plans and avoid missing opportunities for rescue therapy.
引用
- Zhao L, Zhao M, Liu J, et al. Mean apparent diffusion coefficient in a single slice may predict tumor response to whole-brain radiation therapy in non-small-cell lung cancer patients with brain metastases. Eur Radiol. 2021. PMID: 33452628. doi:10.1007/s00330-020-07584-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。